Animal Model Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the Animal Model Market?
In recent years, there has been significant growth in the size of the animal model market. It is predicted to expand from a market value of $1.92 billion in 2024 to $2.09 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.0%. The growth witnessed in the past can be credited to factors like the increased use of animal models for biomedical research, high spending and investment in the development and discovery of drugs, an enhanced focus on precision medicine, and the widespread use of animal models throughout the healthcare industry.

It is anticipated that the animal model market will experience robust growth in the coming years, with projections seeing it climb to $2.92 billion by 2029, thanks to a compound annual growth rate (CAGR) of 8.8%. Contributing factors in this anticipated growth during the forecast period are down to progress in genetic engineering, a heightened emphasis on personalized medicine, a rising prevalence of chronic diseases, an increasing need for efficient vaccines and therapeutics, and larger investments into biomedical research. Expected trends throughout the forecast period comprise a rising demand for animal models in drug discovery and development, increased incidence of chronic diseases, shortened drug development durations due to physiological similarities between humans and animals, enhanced usage of personalized medicine amplifying the demand for humanized mice models, and significant market growth due to increased utilization of animal models for biomedical research.

What Key Elements Are Boosting Growth in the Animal Model Market?
The expansion of the animal model market is projected to be fueled by escalating investment activities in pharmaceutical research and development. The intricate process of pharmaceutical research and development, where science and innovation unify to produce medical progress, is seeing a surge due to the emergence of innovative treatments. These treatments target complex diseases and invigorate scientific curiosity along with potential commercial prospects in the healthcare sector, steering the research and development process. Playing a pivotal role in pharmaceutical research and development, animal models are indispensable for forecasting drug performance, safety levels, and potential toxicity. They offer invaluable glimpses into biological processes and assist in the formulation of new treatment methods by simulating human physiological reactions and disease progression in regulated surroundings. For example, the European Federation of Pharmaceutical Industries and Associations, a trade and advocacy organization based in Belgium, stated in June 2023 that expenditure on pharmaceutical research and development in Europe was €44,500 ($47,999) in 2022 and €42,533 million ($45,877 million) in 2021. Hence, the escalation in pharmaceutical research and development investment is accelerating the growth of the animal model market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

Which Businesses Are at the Forefront of Animal Model Market Development?
Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd., Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd., Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

What Are the Latest Innovations in the Animal Model Market?
Major businesses in the animal model market are honing their focus on the innovation of new products, such as triple-immunodeficient animal models. These new models aim to amplify the precision and trustworthiness of preclinical trials, bolster advanced biomedical research, and aid the creation of groundbreaking treatments for complicated human ailments. Triple-immunodeficient animal models are meticulously crafted animals, most often mice, that are without three crucial elements of the immune system. Such models have become invaluable in biomedical research due to their aptitude for studying human diseases and forming new treatments. To illustrate, Charles River Laboratories International, Inc., a pharmaceutical firm located in the United States, launched NCG mouse strains, a triple-immunodeficient model for oncology research in January 2024. NCG mice, which lack effective/mature T, B, and NK cells and demonstrate diminished macrophage and dendritic cell function, are triple immunodeficient. They can host xenograft cells, tissues, and components of the human immune system. This mouse model is optimal for studies within oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant. NCG mice also have the potential to generate humanized mice by grafting PBMCs or CD34+ stem cells, closely imitating the human immune system.

How Is the Animal Model Market Segmented?
The animal model market covered in this report is segmented -

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:
1) By Mice: inbred* Mice, Outbred Mice, Knockout Mice, Transgenic Mice
2) By Rat: inbred* Rats, Outbred Rats, Transgenic Rats, Knockout Rats
3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs
4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds
5) By Hamsters: Syrian Hamsters, Chinese Hamsters
6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Where Is the Animal Model Market Growth Most Prominent?
North America was the largest region in the animal model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Animal Model Global Market Report?

- Market Size Analysis: Analyze the Animal Model Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Animal Model Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Animal Model Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Animal Model Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15510

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.